Fosun Pharma: Progress on Asset Sale Planning, Special Fund Has Paid-in Capital of 30 Million Yuan

K-LinePoet · 2026-03-29T15:08:21+00:00

Fosun Pharma Announcement: As of the date of this announcement, the special fund has completed business registration and has received the first capital contribution from all partners totaling RMB 30 million. It is still pending registration with the China Securities Investment Fund Industry Association (CSIIA). On March 24, 2026, the relevant parties signed a Supplementary Agreement to the Framework Agreement, agreeing to extend the latest signing date of the Transfer Agreement to September 30, 2026.

K-LinePoet

2026-03-29 15:08:21

Fosun Pharmaceutical Announcement: As of the date of this announcement, the special fund has completed the industrial and commercial registration and has received the initial paid-in capital contributions from all partners in the total amount of RMB 30 million; it is still pending completion of the filing with the Asset Management Association of China (AMAC). On March 24, 2026, the relevant parties signed a “Supplemental Agreement” with respect to the “Framework Agreement,” agreeing to adjust the latest date for signing the “Transfer Agreement” to September 30, 2026.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes